Education
About Us
Working with TipRanks
Follow Us
Consun Pharmaceutical Group Ltd. (HK:1681)
:1681
RESEARCH TOOLSreports
Total Valuation
Consun Pharmaceutical Group Ltd. has a market cap or net worth of €9.29B. The enterprise value is HK$837.40M.
Market Cap€9.29B
Enterprise ValueHK$837.40M
Share Statistics
Consun Pharmaceutical Group Ltd. has 851,976,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding851,976,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Consun Pharmaceutical Group Ltd.’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.82%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)19.82%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee937.81K
Profits Per Employee322.41K
Employee Count3,164
Asset Turnover0.51
Inventory Turnover2.50
Valuation Ratios
The current PE Ratio of Consun Pharmaceutical Group Ltd. is 6.90. Consun Pharmaceutical Group Ltd.’s PEG ratio is 0.26.
PE Ratio6.90
PS Ratio0.00
PB Ratio0.90
Price to Fair Value1.53
Price to FCF3.16
Price to Operating Cash Flow2.98
PEG Ratio0.26
Income Statement
In the last 12 months, Consun Pharmaceutical Group Ltd. had revenue of 2.97B and earned 910.46M in profits. Earnings per share was 1.11.
Revenue2.97B
Gross Profit2.24B
Operating Income1.05B
Pretax Income1.02B
Net Income910.46M
EBITDA1.05B
Earnings Per Share (EPS)1.11
Cash Flow
In the last 12 months, operating cash flow was 350.34M and capital expenditures -46.92M, giving a free cash flow of 303.42M billion.
Operating Cash Flow350.34M
Free Cash Flow303.42M
Free Cash Flow per Share0.36
Dividends & Yields
Consun Pharmaceutical Group Ltd. pays an annual dividend of HK$0.3, resulting in a dividend yield of 6.01%
Dividend Per ShareHK$0.3
Dividend Yield6.01%
Payout Ratio24.98%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change118.01%
50-Day Moving Average9.70
200-Day Moving Average8.00
Relative Strength Index (RSI)67.99
Average Volume (3m)2.46M
Important Dates
Consun Pharmaceutical Group Ltd. upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateJun 10, 2025
Financial Position
Consun Pharmaceutical Group Ltd. as a current ratio of 3.32, with Debt / Equity ratio of 14.63%
Current Ratio3.32
Quick Ratio3.11
Debt to Market Cap0.04
Net Debt to EBITDA-2.52
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Consun Pharmaceutical Group Ltd. has paid 102.73M in taxes.
Income Tax102.73M
Effective Tax Rate0.10
Enterprise Valuation
Consun Pharmaceutical Group Ltd. EV to EBITDA ratio is 3.48, with an EV/FCF ratio of 0.00.
EV to Sales1.23
EV to EBITDA3.48
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Consun Pharmaceutical Group Ltd. has €3.87B in cash and marketable securities with ¥267.17M in debt, giving a net cash position of -€3.60B billion.
Cash & Marketable Securities€3.87B
Total Debt¥267.17M
Net Cash-€3.60B
Net Cash Per Share-€4.22
Tangible Book Value Per Share€5.02
Margins
Gross margin is 75.35%, with operating margin of 35.22%, and net profit margin of 30.68%.
Gross Margin75.35%
Operating Margin35.22%
Pretax Margin34.38%
Net Profit Margin30.68%
EBITDA Margin35.27%
EBIT Margin32.86%
Analyst Forecast
The average price target for Consun Pharmaceutical Group Ltd. is €9.96, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€9.96
Price Target Upside-10.79% Downside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast12.70%
EPS Growth Forecast9.91%